West Pharmaceutical Services Sets Third-Quarter Earnings Date
West Pharmaceutical Services, a primary provider of injectable drug delivery systems, will release its financial results for the third quarter of 2026 on the morning of October 29. The company has scheduled a conference call at 8:00 a.m. Eastern Time to review these figures and provide updated business guidance.
Investors can access the live webcast through the company’s investor relations portal. Those intending to participate in the question-and-answer session must complete an advance registration process to receive a dedicated dial-in number and PIN. A slide presentation accompanying the discussion will be published on the firm’s website when the market opens that morning.
Headquartered in Exton, Pennsylvania, the company maintains a global footprint of 50 sites and 26 manufacturing facilities. West, which reported $3.07 billion in net sales during fiscal year 2025, continues to support the pharmaceutical industry by supplying over 41 billion components and devices annually. An archived version of the webcast will remain accessible online for 90 days following the event.
Comments (0)
No comments yet. Be the first!